DE3061597D1 - Analgesic mixture of nalbuphine and acetaminophen - Google Patents

Analgesic mixture of nalbuphine and acetaminophen

Info

Publication number
DE3061597D1
DE3061597D1 DE8080102696T DE3061597T DE3061597D1 DE 3061597 D1 DE3061597 D1 DE 3061597D1 DE 8080102696 T DE8080102696 T DE 8080102696T DE 3061597 T DE3061597 T DE 3061597T DE 3061597 D1 DE3061597 D1 DE 3061597D1
Authority
DE
Germany
Prior art keywords
nalbuphine
acetaminophen
analgesic mixture
analgesic
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8080102696T
Other languages
German (de)
English (en)
Inventor
John Raymond Dudzinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
EI Du Pont de Nemours and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EI Du Pont de Nemours and Co filed Critical EI Du Pont de Nemours and Co
Application granted granted Critical
Publication of DE3061597D1 publication Critical patent/DE3061597D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8080102696T 1979-05-18 1980-05-15 Analgesic mixture of nalbuphine and acetaminophen Expired DE3061597D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/040,281 US4237140A (en) 1979-05-18 1979-05-18 Analgesic mixture of nalbuphine and acetaminophen

Publications (1)

Publication Number Publication Date
DE3061597D1 true DE3061597D1 (en) 1983-02-17

Family

ID=21910135

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8080102696T Expired DE3061597D1 (en) 1979-05-18 1980-05-15 Analgesic mixture of nalbuphine and acetaminophen

Country Status (12)

Country Link
US (1) US4237140A (enExample)
EP (1) EP0019282B1 (enExample)
JP (1) JPS55154917A (enExample)
AU (1) AU529764B2 (enExample)
CA (1) CA1139671A (enExample)
DE (1) DE3061597D1 (enExample)
HU (1) HU178867B (enExample)
IE (1) IE49988B1 (enExample)
IL (1) IL60095A (enExample)
NZ (1) NZ193695A (enExample)
PH (1) PH15265A (enExample)
ZA (1) ZA802916B (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
US4366159A (en) * 1981-09-08 1982-12-28 Michael Richard Magruder Nalbuphine-narcotic analgesic composition and method of producing analgesia
US4404211A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and flurbiprofen
US4407805A (en) * 1982-06-30 1983-10-04 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and zomepirac
US4404208A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and tiflamizole
US4404210A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and ibuprofen
US4404209A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and sulindac
US4407804A (en) * 1982-06-30 1983-10-04 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and indomethacin
US4402962A (en) * 1982-06-30 1983-09-06 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and 4,5-bis(4-methoxyphenyl)-2-(trifluoromethylsulfonyl)-1H-imidazole
AU565634B2 (en) * 1982-06-30 1987-09-24 E.I. Du Pont De Nemours And Company Synergistic compositions of nalbuphine and non-narcotic analgesic compounds
AU558485B2 (en) * 1982-07-22 1987-01-29 Richardson-Vicks Inc. Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4777174A (en) * 1982-07-22 1988-10-11 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4656177A (en) * 1982-07-22 1987-04-07 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4600579A (en) * 1983-06-07 1986-07-15 Mallinckrodt, Inc. N-acetyl-p-aminophenol compositions containing partially gelatinized starch and method for preparing same
US4722928A (en) * 1985-12-02 1988-02-02 E. I. Du Pont De Nemours And Company N-oxide prodrug derivatives of 3-hydroxy morphinans and partial morphinans having improved oral bioavailability, pharmaceutical compositions, and processes
DE122004000032I2 (de) 1991-09-06 2006-02-09 Mcneilab Inc Zusammensetzung die eine Tramadol-Verbindung und Acetaminophen enth{lt, und ihre Verwendung
US5558876A (en) * 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
TR200001942T2 (tr) 1997-12-22 2000-11-21 Euro-Celtique, S.A. Opioid agonist/antagonist kombinasyonlar
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
SI2283842T1 (sl) 2000-02-08 2015-07-31 Euro-Celtique S.A. Oralne formulacije opioidnih agonistov, varne pred zlorabo
EP1387673B1 (en) 2001-05-11 2010-12-29 Endo Pharmaceuticals Inc. Abuse-resistant controlled-release opioid dosage form
DK1416842T3 (da) 2001-07-18 2009-03-16 Euro Celtique Sa Farmaceutiske kombinationer af oxycodon og naloxon
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
ES2326794T3 (es) 2001-08-06 2009-10-20 Euro-Celtique S.A. Formulaciones de agonistas opioides con antagonista liberable y secuestrado.
US20030157168A1 (en) 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
LT2425821T (lt) 2002-04-05 2017-07-25 Euro-Celtique S.A. Farmacinis preparatas, turintis oksikodono ir naloksono
SI1551372T1 (en) 2002-09-20 2018-08-31 Alpharma Pharmaceuticals Llc SUBVENCATION DATA AND RELATED CONSTRUCTIONS AND PROCEDURES
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
CA2620224C (en) 2005-08-24 2015-11-24 Penwest Pharmaceuticals Company Sustained release formulations of nalbuphine
US8394812B2 (en) 2005-08-24 2013-03-12 Penwest Pharmaceuticals Co. Sustained release formulations of nalbuphine
SI2484346T1 (sl) 2006-06-19 2017-05-31 Alpharma Pharmaceuticals Llc Farmacevtski sestavki
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
PL2405915T3 (pl) 2009-03-10 2019-05-31 Euro Celtique Sa Kompozycje farmaceutyczne o natychmiastowym uwalnianiu zawierające oksykodon i nalokson
KR20160034352A (ko) 2013-07-23 2016-03-29 유로-셀티큐 에스.에이. 장내 세균총이상을 초래하고/하거나 장내 박테리아 전위에 대한 위험을 증가시키는 질환과 통증으로 인해 고통받고 있는 환자에서 통증을 치료하는데 사용하기 위한 옥시코돈과 날록손의 조합물
EA201990684A1 (ru) 2013-12-24 2020-12-30 Вирджиния Коммонвелт Юниверсити Способы применения оксигенированных холестеролсульфатов (ocs)
JOP20190094A1 (ar) * 2016-10-27 2019-04-25 Broad Inst Inc مركبات 1، 2، 4-تريازولون تحمل ثلاثة بدائل عند المواقع 2، 4، 5 مفيدة كمثبطات لديهيدروجيناز ثنائي هيدرو أوروتات (dhodh)
US11260048B2 (en) 2017-10-03 2022-03-01 The Schepens Eye Research Institute, Inc. Compounds and compositions for inhibiting retinal pigment epithelium degeneration and methods using the same
JP7318987B2 (ja) * 2018-09-03 2023-08-01 ジェイコブ バイオテック リミテッド セバコイルジナルブフィンとアセトアミノフェンの医薬品製剤及び疼痛を治療する方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL26896A (en) * 1966-01-19 1970-11-30 Endo Lab 14 - Hydroxynormorphinins and 14 - Hydroxynormorphinones
US4029798A (en) * 1975-06-02 1977-06-14 Sumitomo Chemical Company, Limited Analgetic composition
JPS5946205B2 (ja) * 1976-01-01 1984-11-10 科研製薬株式会社 ベンゾイル誘導体を有効成分とする消炎鎮痛剤

Also Published As

Publication number Publication date
NZ193695A (en) 1984-05-31
AU5835180A (en) 1980-11-20
EP0019282A1 (en) 1980-11-26
IE49988B1 (en) 1986-01-22
PH15265A (en) 1982-11-02
JPH0144684B2 (enExample) 1989-09-29
IE801019L (en) 1980-11-18
IL60095A (en) 1982-12-31
AU529764B2 (en) 1983-06-16
EP0019282B1 (en) 1983-01-12
JPS55154917A (en) 1980-12-02
CA1139671A (en) 1983-01-18
US4237140A (en) 1980-12-02
ZA802916B (en) 1981-12-30
HU178867B (en) 1982-07-28
IL60095A0 (en) 1980-07-31

Similar Documents

Publication Publication Date Title
AU529764B2 (en) Analgesic mixture of nalbuphine and acetaminophen
PT81583A (en) Process for the preparation of analgesic pharmaceutical compositions containing buprenorphine and natrexone
ZA873729B (en) Mixture for manufacture of shaped elements and its use
JPS56890A (en) Manufacture of hydrocarbon mixture
ZA849680B (en) Analgesic and anti-inflammatory compositions comprising xanthine and methods of using same
IL54795A (en) Analgesic compositions comprising substituted bicyclic and spiroaliphatic amines and certain novel compounds of these types
AU8258282A (en) Analgesic compositions and methods of use
PH17898A (en) Analgesic mixture of nalsuphine and isuprofen
GB2134786B (en) Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
JPS5592379A (en) Phenolglycidylether or isomer mixture of phenolglycidylether and their manufacture
JPS55113749A (en) Manufacture of polyaminoopolyaryllpolymethylene type polyamine mixture
ZA804689B (en) Method of administering propranolol and novel dosage forms containing same
PH18216A (en) Analgesic mixture of nalbuphine and tiflamizole
GB2047534B (en) Analgesic and myotonolytic compositions
PH18219A (en) Analgesic mixture of nalbuphine and zomepirac
PH17939A (en) Analgesic mixture of nalbuphine and indomethacin
IL61039A0 (en) Preparation of 1-azolyl-1-phenoxy-alkan-2-ones and 1-azolyl-1-halo-alkan-2-ones used therefor
JPS5645444A (en) Manufacture of mixture of 33chloroanthranilic alkylester and 66chloroanthranilic alkylester
ZA802578B (en) Preparation of aryl-monourethanes and aryl-polyurethanes
PH17903A (en) Analgesic mixture of nalbuphine and sulindac
PH17913A (en) Analgesic mixture of nalbuphine and flurbiprofen
IL61273A0 (en) Preparation of anilines and certain novel anilines
JPS5616434A (en) Manufacture of 22 and 44hydroxybenzylalcohol mixture
JPS5622754A (en) Nnmmtrifluoromethylphenylanthranilate of ooalkoxycarbonylphenyl* its manufacture and its use
DE3064277D1 (en) Analgesic mixture of nalbuphine and acetylsalicylic acid, derivative or salt thereof

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: THE DU PONT MERCK PHARMACEUTICAL CO., WILMINGTON,

8328 Change in the person/name/address of the agent

Free format text: VON KREISLER, A., DIPL.-CHEM. SELTING, G., DIPL.-ING. WERNER, H., DIPL.-CHEM. DR.RER.NAT. FUES, J., DIPL.-CHEM. DR.RER.NAT. BOECKMANN GEN. DALLMEYER, G., DIPL.-ING. HILLERINGMANN, J., DIPL.-ING. JOENSSON, H., DIPL.-CHEM. DR.RER.NAT. MEYERS, H., DIPL.-CHEM. DR.RER.NAT., PAT.-ANWAELTE, 5000 KOELN

8339 Ceased/non-payment of the annual fee